Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
https://www.zacks.com/stock/news/2322488/stereotaxis-stxs-achieves-ce-mark-in-europe-for-genesisx?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322488
Aug 15, 2024 - Stereotaxis (STXS) gets a CE mark in Europe for its GenesisX robotic system. Following this, the company also submits a 501(k) application for FDA clearance.
0
Labcorp (LH) Gains From New Collaborations Amid FX Issues
https://www.zacks.com/stock/news/2322253/labcorp-lh-gains-from-new-collaborations-amid-fx-issues?cid=CS-ZC-FT-analyst_blog|zer_report_update-2322253
Aug 14, 2024 - Labcorp's (LH) Biopharma Laboratory Services business is benefiting from collaborations with leading pharmaceutical and biotechnology companies.
0
Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook
https://www.zacks.com/stock/news/2321579/neuronetics-stim-inks-a-new-merger-agreement-with-greenbrook?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2321579
Aug 13, 2024 - Neuronetics (STIM) signs a merger agreement with Greenbrook to acquire all its outstanding shares. The transaction is expected to be closed during the fourth quarter of 2024.
0
Can Intuitive Surgical (ISRG) Run Higher on Rising Earnings Estimates?
https://www.zacks.com/stock/news/2321536/can-intuitive-surgical-isrg-run-higher-on-rising-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2321536
Aug 13, 2024 - Intuitive Surgical (ISRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Quest Diagnostics (DGX) Gains From Innovation, Customer Wins
https://www.zacks.com/stock/news/2321446/quest-diagnostics-dgx-gains-from-innovation-customer-wins?cid=CS-ZC-FT-analyst_blog|zer_report_update-2321446
Aug 13, 2024 - A key driver in Brain Health growth is Quest Diagnostics' (DGX) Alzheimer's disease portfolio, featuring the AD-Detect blood testing services and the CSF Tests for diagnosing and monitoring.
0
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
https://www.zacks.com/stock/news/2318347/charles-river-crl-q2-earnings-beat-estimates-2024-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2318347
Aug 07, 2024 - Charles River's (CRL) Manufacturing business segments report organic revenue growth, partially offset by lower revenues in the DSA and RMS segments.
0
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
https://www.fool.com/investing/2024/08/03/prediction-2-stocks-that-will-be-worth-more-than-j/?source=iedfolrf0000001
Aug 03, 2024 - These two healthcare companies have far more upside potential than Johnson & Johnson.
0
Top Research Reports for Microsoft, Meta & JPMorgan Chase
https://www.zacks.com/commentary/2311674/top-research-reports-for-microsoft-meta-jpmorgan-chase?cid=CS-ZC-FT-research_daily-2311674
Jul 30, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Meta Platforms, Inc. (META) and JPMorgan Chase & Co. (JPM), as well a micro-cap stock Applied Energetics, Inc. (AERG).
0
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500
https://www.fool.com/investing/2024/07/27/2-unstoppable-growth-stocks-to-buy-right-now-for/?source=iedfolrf0000001
Jul 27, 2024 - Even if you have a modest amount to invest, building a small position in great companies can get you started.
0
3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now
https://www.zacks.com/stock/news/2310285/3-reasons-why-you-should-hold-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2310285
Jul 26, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
0